Conclusions
stoma
RECTAL TUMORS, COMPLICATIONS
In this prospective phase II multicenter North American trial, the procedural and preliminary oncologic safety of taTME was demonstrated. In a predominantly male cohort with low rectal tumors and median BMI 27.8, a 2-team taTME approach achieved acceptable rates of complete and near-complete mesorectal grade with a low rate of open conversion. Continued monitoring and management of anastomotic complications resulted in high stoma closure rates.